Table 2 Summary of cross reactivity study.
From: Development, evaluation of the PNA RT-LAMP assay for rapid molecular detection of SARS-CoV-2
Microorganisms | Hit rate (#detected/#tested) | Result | ||||
|---|---|---|---|---|---|---|
A well | B well | |||||
ORF1ab | RNase P | N | RNase P | |||
1 | Human coronavirus 229E | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
2 | Human coronavirus OC43 | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
3 | Human coronavirus HKU1 | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
4 | Human coronavirus NL63 | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
5 | SARS-coronavirus | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
6 | MERS-coronavirus | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
7 | Adenovirus type 1 | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
8 | Adenovirus type 2 | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
9 | Adenovirus type 3 | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
10 | Human Metapneumovirus | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
11 | Parainfluenza virus 1 | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
12 | Parainfluenza virus 2 | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
13 | Parainfluenza virus 3 | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
14 | Parainfluenza virus 4 | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
15 | Influenza A (H3N2) | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
16 | Influenza A (H1N1) | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
17 | Influenza B | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
18 | Enterovirus | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
19 | Respiratory syncytial virus | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
20 | Rhinovirus 1 | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
21 | Rhinovirus 14 | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
22 | Rhinovirus 7 | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
23 | Chlamydia pneumoniae | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
24 | Haemophilus influenzae | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
25 | Legionella pneumophila | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
26 | Mycobacterium tuberculosis | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
27 | Streptococcus pneumoniae | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
28 | Streptococcus pyogenes | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
29 | Bordetella pertussis | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
30 | Mycoplasma pneumoniae | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
31 | Candida albicans | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
32 | Pseudomonas aeruginosa | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
33 | Staphylococcus epidermis | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
34 | Streptococcus salivarius | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
35 | Staphylococcus aureus | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
36 | Human nasal wash | 0% (0/3) | 100% (3/3) | 0% (0/3) | 100% (3/3) | Negative |
